Heidelberg Pharma AG announced that Walter Miller has been appointed Chief Financial Officer effective May 1, 2023. dr Jan Schmidt-Brand, who has held a dual role since 2014, will remain Spokesman of the Management Board/CEO and will hand over his responsibilities as CFO to Walter Miller. Walter Miller was most recently CFO of Optimapharm Group, a Clinical Research Organization (CRO) headquartered in Zagreb, Croatia, where he was responsible for finance, MA and administration.

He has many years of experience in corporate finance, MA, strategic controlling, accounting and corporate development, both in biotech companies and at CROs. Before Optimapharm, Mr. Miller was CFO at Mologen AG, Berlin, and CFO at the Nuvisan Group, headquartered in Neu-Ulm, as well as more than ten years in senior finance positions at Santhera Pharmaceuticals, Pratteln, Switzerland. He holds a degree in business administration from Aachen University.